This article has been corrected from a previous version, which described Lucidyx as a British company. The firm is based in Westlake, Ohio.
NEW YORK, June 24 (GenomeWeb News) - The Biosystems Informatics Institute and Lucidyx will co-develop new bioinformatics tools to integrate data storage and Lucidyx's genomic search engine in an attempt to "better contextualize off-target drug effects," the groups said yesterday.
These tools may play a role in researchers' attempts to "further understand the data flowing from proteomics and transcriptomics experiments across the industry," Ian Humphrey-Smith, chief executive officer of the BII, said in a statement.
Terms of the agreement between the groups call for BII to help Lucidyx develop products that could enable life-science software researchers developing tools to access genomic data through application programming interfaces to query and retrieve information from Lucidyx's genomic annotation search engine Searcher.
The collaboration "focuses" on the development of Lucidyx Oracle Gateway, designed to be a "bridge" between Oracle and the Lucidyx search engine that allows Oracle SQL queries to combine data from Oracle with data from Searcher "as if all the data was stored in Oracle tables," according to the statement.
Financial terms of the alliance were not disclosed.